SWTXSpringWorks Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsJul 30
Mkt Cap$3.54B
Vol5.01M

About

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
368

Frequently Asked Questions

What is Market Cap of SpringWorks Therapeutics Inc?
What is the 52-week high for SpringWorks Therapeutics Inc?
What is the 52-week low for SpringWorks Therapeutics Inc?
What is SpringWorks Therapeutics Inc stock price today?
What was SpringWorks Therapeutics Inc stock price yesterday?
What is the PE ratio of SpringWorks Therapeutics Inc?
What is the Price-to-Book ratio of SpringWorks Therapeutics Inc?
What is the 50-day moving average of SpringWorks Therapeutics Inc?
How many employees does SpringWorks Therapeutics Inc have?

Advertisement|Remove ads.